BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32636682)

  • 1. Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics Analyses.
    Wu Y; Xia L; Guo Q; Zhu J; Deng Y; Wu X
    Cancer Manag Res; 2020; 12():5213-5223. PubMed ID: 32636682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Analysis To Identify Molecular Biomarkers Of High-Grade Serous Ovarian Cancer.
    Si M; Zhang J; Cao J; Xie Z; Shu S; Zhu Y; Lang J
    Onco Targets Ther; 2019; 12():10057-10075. PubMed ID: 31819501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
    Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
    Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein anabolism is key to long-term survival in high-grade serous ovarian cancer.
    Wang L; Sun T; Li S; Zhang Z; Jia J; Shan B
    Transl Oncol; 2021 Jan; 14(1):100885. PubMed ID: 33045680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis.
    Yang X; Zhu S; Li L; Zhang L; Xian S; Wang Y; Cheng Y
    Onco Targets Ther; 2018; 11():1457-1474. PubMed ID: 29588600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma.
    Bao L; Zhao Y; Liu C; Cao Q; Huang Y; Chen K; Song Z
    J Cancer; 2020; 11(7):1712-1726. PubMed ID: 32194783
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
    Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
    Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key genes and pathways in pelvic organ prolapse based on gene expression profiling by bioinformatics analysis.
    Zhou Q; Hong L; Wang J
    Arch Gynecol Obstet; 2018 May; 297(5):1323-1332. PubMed ID: 29546564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
    Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
    PeerJ; 2019; 7():e7408. PubMed ID: 31392101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
    Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
    Front Genet; 2020; 11():530892. PubMed ID: 33061942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer.
    Liu H; Zhou L; Cheng H; Wang S; Luan W; Cai E; Ye X; Zhu H; Cui H; Li Y; Chang X
    Chin Med J (Engl); 2023 Dec; 136(24):2974-2982. PubMed ID: 37284741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational-based identification and analysis of globally expressed differential genes in high-grade serous ovarian carcinoma cell lines.
    Masood F; Khan W; Uddin R
    Comput Biol Chem; 2020 Oct; 88():107333. PubMed ID: 32738584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.
    Chen B; Hua Z; Qin X; Li Z
    Neurochem Res; 2021 Feb; 46(2):197-212. PubMed ID: 33104965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.